Active Ingredient History

  • Now
Obinutuzumab, sold under the brand name Gazyva among others, is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)



United States

$4690.1600 - $6417.4300
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

afutuzumab | ga101 | ga 101 | ga-101 | ga101 antibody | gazyva | gazyvaro | humabcd20 | humab | immunoglobulin g1, anti-(human cd20 (antigen)) (human-mouse monoclonal ga101 heavy chain), disulfide with human-mouse monoclonal ga101 kappa-chain, dimer | obinutuzumab | r 7159 | r-7159 | r7159 cpd | rg-7159 | ro5072759 | ro 5072759 | ro-5072759 | ro-5072759 humab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue